The level of DNA modification by (+)-syn-(11S,12R,13S,14R)- and (-)-anti-(11R,12S,13S,14R)-dihydrodiol epoxides of dibenzo[a,l]pyrene determined the effect on the proteins p53 and p21WAF1 in the human mammary carcinoma cell line MCF-7.

The polycyclic aromatic hydrocarbon (PAH) dibenzo[a,l]pyrene (DB[a,l]P), the most carcinogenic PAH tested in rodent bioassays, exerts its pathobiological activity via metabolic formation of electrophilically reactive DNA-binding fjord region (+)-syn-(11S,12R,13S,14R)- or (-)-anti-(11R,12S,13S,14R)-DB[a,l]P-dihydrodiol epoxides (DB[a,l]-PDEs). DB[a,l]P is metabolized to these DB[a,l]PDEs which bind to DNA in human mammary carcinoma MCF-7 cells. The molecular response of MCF-7 cells to DNA damage caused by DB[a,l]PDEs was investigated by analyzing effects on the expression of the tumor suppressor protein p53 and one of its target gene products, the cyclin-dependent kinase inhibitor p21WAF1. Treatment of MCF-7 cells with (+)-syn- and (-)-anti-DB[a,l]PDE at a concentration range of 0.001-0.1 microM resulted in DB[a,l]PDE-DNA adduct levels between 2 and 30, and 3 and 80 pmol/mg DNA, respectively, 8 h after exposure. (-)-anti-DB[a,l]PDE exhibited a higher binding efficiency that correlated with a significantly stronger p53 response at low concentrations of the dihydrodiol epoxides. The level of p53 increased by 6-8 h after treatment. The p21WAF1 protein amount exceeded control levels by 12 h and remained elevated for 96 h. At a dose of 0.01 microM (+)-syn-DB[a,l]PDE, an increase in p21WAF1 was observed in the absence of a detectable change in p53 levels. The results indicate that the increase in p53 induced by DB[a,l]PDEs in MCF-7 cells requires an adduct level of approximately 15 pmot/mg DNA and suggest that the level of adducts rather than the specific structure of the DB[a,l]PDE-DNA adduct formed triggers the p53 response. The PAH-DNA adduct level formed may determine whether p53 and p21VAF1 pathways respond, resulting in cell-cycle arrest, or fail to respond and increase the risk of mutation induction by these DNA lesions.

[1]  A. Luch,et al.  Relationship of Dibenzo[a, l]pyrene-DNA Binding to the Induction of p53, p21 WAFI and Cell Cycle Arrest in Human Cells in Culture , 2000 .

[2]  C. Smith,et al.  Formation of stable adducts and absence of depurinating DNA adducts in cells and DNA treated with the potent carcinogen dibenzo[a,l]pyrene or its diol epoxides. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[3]  K. Vousden,et al.  Cellular response to DNA damage from a potent carcinogen involves stabilization of p53 without induction of p21(waf1/cip1). , 1997, Carcinogenesis.

[4]  H. Glatt,et al.  Metabolic activation of the (+)-S,S- and (-)-R,R-enantiomers of trans-11,12-dihydroxy-11,12-dihydrodibenzo[a,l]pyrene: stereoselectivity, DNA adduct formation, and mutagenicity in Chinese hamster V79 cells. , 1997, Chemical research in toxicology.

[5]  A. Luch,et al.  Stereoselective activation of dibenzo[a,l]pyrene and its trans-11,12-dihydrodiol to fjord region 11,12-diol 13,14-epoxides in a human mammary carcinoma MCF-7 cell-mediated V79 cell mutation assay. , 1997, Chemical research in toxicology.

[6]  W. Baird,et al.  anti-Benzo[a]pyrene-7,8-diol-9,10-epoxide Treatment Increases Levels of the Proteins p53 and p21WAF1 in the Human Mammary Carcinoma Cell Line MCF-7 , 1996 .

[7]  J. Chuang,et al.  Human exposure and dosimetry of polycyclic aromatic hydrocarbons in urine from Xuan Wei, China with high lung cancer mortality associated with exposure to unvented coal smoke. , 1995, Carcinogenesis.

[8]  A. Luch,et al.  Stereoselective activation of dibenzo[a,l]pyrene to (-)-anti (11R,12S,13S,14R)- and (+)-syn(11S,12R,13S,14R)-11,12-diol-13,14-epoxides which bind extensively to deoxyadenosine residues of DNA in the human mammary carcinoma cell line MCF-7. , 1995, Carcinogenesis.

[9]  S. Amin,et al.  Tumorigenicity in newborn mice of fjord region and other sterically hindered diol epoxides of benzo[g]chrysene, dibenzo[a,l]pyrene (dibenzo[def,p]chrysene), 4H-cyclopenta[def]chrysene and fluoranthene. , 1995, Carcinogenesis.

[10]  P. Glazer,et al.  Induction of p53 in mouse cells decreases mutagenesis by UV radiation. , 1995, Carcinogenesis.

[11]  P. Hanawalt,et al.  Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Rämet,et al.  p53Protein expression is correlated with benzo[a]pyrene-DNA adducts in carcinoma cell lines , 1995 .

[13]  G. Stark,et al.  p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Amin,et al.  Mammary carcinogenicity in female CD rats of fjord region diol epoxides of benzo[c]phenanthrene, benzo[g]chrysene and dibenzo[a,l]pyrene. , 1995, Carcinogenesis.

[15]  E. Cavalieri,et al.  Identification and quantitation of dibenzo[a,l]pyrene--DNA adducts formed by rat liver microsomes in vitro: preponderance of depurinating adducts. , 1995, Biochemistry.

[16]  N. H. Velthorst,et al.  Direct Determination of Dibenzo[a,l]pyrene in Crude Extracts of Environmental Samples by Laser-Excited Shpol'skii Spectroscopy , 1995 .

[17]  L. Hartwell,et al.  Cell cycle control and cancer. , 1994, Science.

[18]  M. Sheikh,et al.  Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. , 1994, Oncogene.

[19]  J. Marx.  New link found between p53 and DNA repair. , 1994, Science.

[20]  Kai Ming Li,et al.  Synthesis and tumor-initiating activity in mouse skin of dibenzo[a,l]pyrene syn- and anti-fjord-region diolepoxides. , 1994, Carcinogenesis.

[21]  G. Wahl,et al.  DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. , 1994, Genes & development.

[22]  H. Glatt,et al.  Synthesis and mutagenicity of the diastereomeric fjord-region 11,12-dihydrodiol 13,14-epoxides of dibenzo[a,l]pyrene. , 1994, Carcinogenesis.

[23]  A. Luch,et al.  Identification of Dibenzo[a,l]pyrene-DNA Adducts Formed in Cells in Culture and in Mouse Skin , 1994 .

[24]  K. Vähäkangas,et al.  Benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts and increased p53 protein in mouse skin. , 1994, Carcinogenesis.

[25]  Yi-Song Wang,et al.  WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. , 1994, Cancer research.

[26]  David Beach,et al.  p21 is a universal inhibitor of cyclin kinases , 1993, Nature.

[27]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[28]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[29]  M. Hollstein,et al.  Clinical implications of the p53 tumor-suppressor gene. , 1993, The New England journal of medicine.

[30]  E. LaVoie,et al.  Exceptional tumor-initiating activity of 4-fluorobenzo[j]-fluoranthene on mouse skin: comparison with benzo[j]-fluoranthene, 10-fluoro-benzo[j]fluoranthene, benzo[a]pyrene, dibenzo[a,l]pyrene and 7,12-dimethylbenz[a]anthracene. , 1993, Cancer letters.

[31]  N. V. Ramakrishna,et al.  Tumor-initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin. , 1993, Carcinogenesis.

[32]  M. Fritsche,et al.  Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. , 1993, Oncogene.

[33]  P. Shaw,et al.  Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Sukumar,et al.  Mutations in p53 as potential molecular markers for human breast cancer. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[35]  B. Vogelstein,et al.  Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.

[36]  N. V. Ramakrishna,et al.  Comparative dose-response tumorigenicity studies of dibenzo[a,l]pyrene versus 7, 12-dimethylbenz[a]anthracene, benzo[a and two dibenzo[a,l]pyrene dihydrodiols in mouse skin and rat mammary gland , 1991 .

[37]  W. Baird,et al.  Detection and identification of benzo[a]pyrene-DNA adducts by [35S]phosphorothioate labeling and HPLC. , 1991, Carcinogenesis.

[38]  P. Nurse.  Universal control mechanism regulating onset of M-phase , 1990, Nature.

[39]  S. Kooijman,et al.  Concentrations of polycyclic hydrocarbons in airborne particles in The Netherlands and their correlation with mutagenicity. , 1987, The Science of the total environment.

[40]  J. Chuang,et al.  Indoor air sampling and mutagenicity studies of emissions from unvented coal combustion. , 1987, Environmental science & technology.

[41]  D. Jerina,et al.  Conformational effects in the hydrolyses of rigid benzylic epoxides: implications for diol epoxides of polycyclic hydrocarbons , 1982 .

[42]  M. Snook,et al.  The ldentification of High Molecular Weight Polynuclear Aromatic Hydrocarbons in a Biologically Active Fraction of Cigarette Smoke Condensate , 1977 .

[43]  M. Rämet,et al.  p53 protein expression is correlated with benzo[a]pyrene-DNA adducts in carcinoma cell lines. , 1995, Carcinogenesis.

[44]  M. Reiss,et al.  Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines. , 1992, Oncology research.

[45]  E. Harlow,et al.  Antibodies: A Laboratory Manual , 1988 .

[46]  D. Barnes.  Growth characteristics of A431 human epidermoid carcinoma cells in serum-free medium: inhibition by epidermal growth factor. , 1984, Advances in experimental medicine and biology.

[47]  S. Sukumar,et al.  Mutations in p 53 as potential molecular markers for human breast cancer , 2022 .